Background Most countries have formally adopted the World Health Organization’s 2015
recommendation of universal HIV treatment (“treat all”). However, there are few rigorous …

In sub-Saharan Africa, simple biomarkers of liver fibrosis are needed to scale-up hepatitis B
treatment. We conducted an individual participant data meta-analysis of 3,548 chronic …

Background Few data on the virological determinants of hepatitis B virus (HBV) infection are
available from southern Africa. Methods We enrolled consecutive HIV-infected adult …

Considerable progress has been made over the past decade in epidemiological and
intervention research, service delivery, and increasing awareness of and appreciation for the …

Initiation of antiretroviral therapy during acute HIV-1 infection may prevent persistent immune
activation. We analyzed longitudinal CD38+ HLA-DR+ CD8+ T-cell percentages in 31 …

In an HIV-hepatitis B virus (HIV-HBV) coinfection cohort in Zambia, we piloted a qualitative
point-of-care (POC) test for urine Ethyl glucuronide (uEtG), assessed concordance between …

Introduction By 2020, 90% of all people diagnosed with HIV should receive long‐term
combination antiretroviral therapy (ART). In sub‐Saharan Africa, this target is threatened by loss to …

… Author links open overlay panel Michael J. Vinikoor a b c 1 , Samuel Zürcher d 1 , Kalo
Musukuma b c , Obert Kachuwaire b , Andri Rauch e , Benjamin H. Chi f , Meri Gorgievski d , …

Background Though antiretroviral therapy (ART) is widely available, HIV positive pregnant
women in Zambia are less likely to start and remain on therapy throughout pregnancy and …

With aging of the HIV-infected population, non-AIDS conditions such as cardiovascular disease
(CVD) now account for substantial mortality and morbidity. While myocardial infarction is …